Larson Financial Group’s 2seventy bio TSVT Stock Holding History

Larson Financial Group’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-698	Closed	-$3.45K	–	3499
2025 Q1	$3.45K	Hold	698	–	–	﹤0.01%	1989
2024 Q4	$2.05K	Hold	698	–	–	﹤0.01%	1874
2024 Q3	$3.29K	Hold	698	–	–	﹤0.01%	1757
2024 Q2	$2.69K	Hold	698	–	–	﹤0.01%	1552
2024 Q1	$3.73K	Hold	698	–	–	﹤0.01%	1253
2023 Q4	$2.98K	Hold	698	–	–	﹤0.01%	1293
2023 Q3	$2.74K	Hold	698	–	–	﹤0.01%	1294
2023 Q2	$7.06K	Buy	698 +690	+8,625%	+$7.3K	﹤0.01%	1023
2023 Q1	$82	Hold	8	–	–	﹤0.01%	1507
2022 Q4	$75	Hold	8	–	–	﹤0.01%	1467
2022 Q3	$0	Hold	8	–	–	﹤0.01%	1398
2022 Q2	$0	Hold	8	–	–	﹤0.01%	1297
2022 Q1	$0	Hold	8	–	–	﹤0.01%	1170
2021 Q4	$0	Buy	+8	New	+$250	﹤0.01%	1173

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Larson Financial Group's TSVT Position: Q2 2025 in Review

Larson Financial Group sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 698 shares — an estimated $3.45K sold.

Larson Financial Group first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $7.06K in Q2 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Larson Financial Group reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Larson Financial Group sold 698 2seventy bio shares in Q2 2025, an estimated $3.45K.
Larson Financial Group first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
Larson Financial Group's 2seventy bio position peaked at $7.06K in Q2 2023.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Larson Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.